In one of their reports, Qiu et al. composed a multimodal nanosystem for the specific identification and efficient therapy of pancreatic cancer, based on gold nanocages (AuNCs) functionalized with hyaluronic acid (HA) and conjugated with anti-Glypican-1 (anti-GPC1) antibody, oridonin (ORI), gadolinium (Gd), and Cy7 dye. This evidence concerns the gene GPC1 and familial pancreatic carcinoma.